Clinical Trial Update: Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A completed Phase 1 safety trial evaluated the combination of thioridazine and cytarabine in relapsed or refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• thioridazine (thioridazine)

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED